CK2α as a Prognostic Marker in Colorectal Cancer
Author Information
Author(s): Lin Kai-Yuan, Tai Chein, Hsu Jung-Chin, Li Chien-Feng, Fang Chia-Lang, Lai Hsi-Chin, Hseu You-Cheng, Lin Yi-Feng, Uen Yih-Huei
Primary Institution: Chi-Mei Medical Center, Tainan, Taiwan
Hypothesis
The study investigates the role of nuclear protein kinase CK2α in tumor progression and prognosis in colorectal cancer.
Conclusion
Overexpression of nuclear CK2α can be a useful marker for predicting the outcome of patients with colorectal cancer.
Supporting Evidence
- Nuclear CK2α expression was higher in tumor tissues than in non-tumor tissues.
- High CK2α expression correlated with poorer overall survival rates.
- CK2α was identified as an independent prognostic marker in multi-variate analysis.
Takeaway
This study found that a protein called CK2α is found in higher amounts in colorectal cancer tissues, and having more of it can mean a patient might not live as long.
Methodology
The study analyzed CK2α expression in 245 colorectal tissues using immunohistochemistry, quantitative real-time PCR, and Western blot, correlating findings with clinical parameters.
Participant Demographics
245 colorectal cancer patients, 139 males and 106 females, aged 21 to 88 years.
Statistical Information
P-Value
<0.0001
Confidence Interval
95% CI = 2.46 to 8.32
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website